CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 113 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $156 | -100.0% | 25,000 | -88.3% | 0.00% | -75.0% |
| Q3 2022 | $749,000 | +18.7% | 214,200 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $631,000 | -10.7% | 214,200 | -5.8% | 0.00% | 0.0% |
| Q1 2022 | $707,000 | -7.7% | 227,375 | +0.2% | 0.00% | -25.0% |
| Q4 2021 | $766,000 | +69.5% | 226,850 | +82.9% | 0.00% | +100.0% |
| Q3 2021 | $452,000 | +4.9% | 124,000 | +25.3% | 0.00% | 0.0% |
| Q2 2021 | $431,000 | – | 99,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,787,094 | $26,645,572 | 14.80% |
| Lynx1 Capital Management LP | 994,161 | $14,822,941 | 9.80% |
| Octagon Capital Advisors LP | 3,073,750 | $45,829,613 | 7.04% |
| Saturn V Capital Management LP | 1,124,459 | $16,765,684 | 7.02% |
| Altium Capital Management LP | 800,000 | $11,928,000 | 6.22% |
| Affinity Asset Advisors, LLC | 1,129,376 | $16,838,996 | 4.74% |
| ACUTA CAPITAL PARTNERS, LLC | 418,000 | $6,232,380 | 4.18% |
| Cormorant Asset Management, LP | 3,850,000 | $57,403,500 | 3.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 590,000 | $8,796,900 | 2.67% |
| MPM BioImpact LLC | 610,770 | $9,106,581 | 2.43% |